A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) with Placebo in Achieving Remission in Patients with Active Lupus Nephritis

Trial ID or NCT#

NCT02141672

Status

recruiting iconRECRUITING

Purpose

To assess the efficacy of 2 doses of voclosporin compared to placebo in achieving complete remission after 24 weeks of therapy in subjects with active lupus nephritis.

 

Investigator(s)

Richard Lafayette, MD
SEND MESSAGE

View on ClinicalTrials.gov